TMIC-70. Integrative spatiotemporal proteomic and metabolomic characterization of immune infiltration following intracranial injection of oncolytic immunotherapy in glioblastoma patientsJennifer Gantchev, Nathalie Y.R. Agar, Gerard Baquer et al.|Neuro-Oncology|2025Cited by 0
IMMU-67. On-Treatment Spatiotemporal Profiling of Glioblastoma During Oncolytic ImmunoTherapyCharles Couturier, Nathalie Y.R. Agar, Kaitlyn Bootz et al.|Neuro-Oncology|2025Cited by 0
CTIM-35. MULTI-OMIC AND SINGLE CELL ASSESSMENT OF SERIAL BIOPSIES REVEALS RESPONSES TO CAN-3110 ONCOLYTIC IMMUNOTHERAPY IN RECURRENT GLIOBLASTOMA THAT ARE NOT EVIDENT BY ROUTINE CLINICAL ANALYSESAlexander Ling, E Antonio Chiocca, Jennifer Gantchev et al.|Neuro-Oncology|2025Cited by 0